---
figid: PMC9360236__ajcr0012-2966-f12
pmcid: PMC9360236
image_filename: ajcr0012-2966-f12.jpg
figure_link: /pmc/articles/PMC9360236/figure/fig12/
number: Figure 12
figure_title: ''
caption: 'The prognostic roles of ITGB1-DT-related genes in LUAD patients. A. AREG;
  B. CIDEC; C. CR391992.1; D. CRHR2; E. DKK1; F. EREG; G. FIBCD1; H. KCNF1; I. LAMC2;
  J. LCN1; K. LIPK; L. NTSR1; M. OLFM1; N. TCN1; O. VEGFC. Note: LUAD, lung adenocarcinoma.'
article_title: Interfering with ITGB1-DT expression delays cancer progression and
  promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway.
citation: Dan Li, et al. Am J Cancer Res. 2022;12(7):2966-2988.
year: '2022'

doi: ''
journal_title: American Journal of Cancer Research
journal_nlm_ta: Am J Cancer Res
publisher_name: e-Century Publishing Corporation

keywords:
- ITGB1-DT
- MAPK
- NSCLC
- overall survival
- disease-specific survival
- progression-free interval

---
